Get the Stockscreener App
15.81
0.64%
-0.095
Sotera Health Co stock is traded at $15.81, with a volume of 434.70K.
It is down -0.64% in the last 24 hours and down -12.47% over the past month.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
See More
Previous Close:
$15.91
Open:
$15.51
24h Volume:
434.70K
Relative Volume:
0.23
Market Cap:
$4.50B
Revenue:
$1.11B
Net Income/Loss:
$24.82M
P/E Ratio:
197.69
EPS:
0.08
Net Cash Flow:
$105.89M
1W Performance:
-5.45%
1M Performance:
-12.47%
6M Performance:
-1.07%
1Y Performance:
+35.35%
1-Day Range:
$15.39
$15.83
1-Week Range:
$15.39
$16.98
52-Week Range:
$9.53
$19.85
Sotera Health Co Stock (SHC) Company Profile
Name
Sotera Health Co
Sector
Industry
Phone
440-262-1410
Address
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
15.81 | 4.52B | 1.11B | 24.82M | 105.89M | 0.08 |
|
TMO
Thermo Fisher Scientific Inc
|
509.36 | 191.08B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
202.94 | 145.67B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
635.37 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
118.64 | 33.42B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
310.39 | 30.14B | 3.17B | 642.63M | 516.49M | 10.77 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-26 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-25 | Initiated | William Blair | Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| May-05-25 | Upgrade | Goldman | Neutral → Buy |
| Dec-06-24 | Initiated | Goldman | Neutral |
| May-21-24 | Initiated | Piper Sandler | Neutral |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Mar-25-24 | Upgrade | Jefferies | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Jun-26-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-23-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-11-23 | Upgrade | Barclays | Underweight → Overweight |
| Jan-11-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-15-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-26-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-21-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Sep-20-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-09-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-03-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-02-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-14-21 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Citigroup | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | JP Morgan | Overweight |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | RBC Capital Mkts | Outperform |
View All
Sotera Health Co Stock (SHC) Latest News
Sotera Health (SHC) Loses 13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
SHC Should I Buy - Intellectia AI
Panel: Investors Failed To Show Sterilization Facility Owner Committed Fraud - Law360
Sotera Health wins appeal of investor lawsuit - Crain's Cleveland Business
Sotera Health is Now Oversold (SHC) - Nasdaq
Sotera Prevails in Investor Appeal of Emissions Disclosures Suit - Bloomberg Law News
Sotera Health: Strengthening Fundamentals, Margin Expansion, and Deleveraging Support Buy Rating and $20 Target - TipRanks
Sotera Health Company (NASDAQ:SHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Sotera Health Company (SHC) Stock Analysis: A 16.85% Potential Upside In Healthcare Diagnostics & Research - DirectorsTalk Interviews
Decoding Sotera Health Co (SHC): A Strategic SWOT Insight - GuruFocus
6th Circ. Affirms Dismissal Of Sotera Toxic Gas Investor Suit - Law360
Sotera Health (SHC) Margin Expansion To 6.7% Tests Premium 60.9x P/E Narrative - simplywall.st
SHC: Citigroup Maintains "Buy" Rating, Raises Price Target to $2 - GuruFocus
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% - Investing.com Canada
Sotera Health Co (SHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - GuruFocus
SHC Reports Strong Q4 Revenue, Exceeds Expectations - GuruFocus
SHC's Strong Q4 Revenue Surpasses Expectations with Robust Growt - GuruFocus
Sotera Health reports Q4 adjusted EPS 26c, consensus 24c - TipRanks
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts By Investing.com - Investing.com Canada
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts - Investing.com
Sotera Health General Counsel Alex Dimitrief to transition to outside advisor - TipRanks
Sotera Health earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Sotera Health (NASDAQ:SHC) Issues Quarterly Earnings Results - MarketBeat
SHC Projects Revenue and Earnings Growth for the Year - GuruFocus
Sotera Health (SHC) Announces Leadership Transition in Legal Dep - GuruFocus
Sotera Health Company's (NASDAQ:SHC) Q4 CY2025: Beats On Revenue - Finviz
Sotera Health (NASDAQ:SHC) Issues FY 2026 Earnings Guidance - MarketBeat
Stronger 2025 lifts Sotera Health (NASDAQ: SHC) guidance for 2026 - Stock Titan
Insights into Sotera Health Q4 Earnings - Benzinga
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook - ChartMill
Sotera Health faces earnings test as revenue decline looms - Investing.com Australia
Sotera Health faces earnings test as revenue decline looms By Investing.com - Investing.com Nigeria
Earnings To Watch: Sotera Health Co (SHC) Reports Q4 2025 Result - GuruFocus
Sotera Health Company (SHC) Q4 Earnings Report Preview: What To Look For - Finviz
Irenic Dumps Most Papa John's Shares - The Motley Fool
CenterBook Partners LP Makes New $1.23 Million Investment in Sotera Health Company $SHC - MarketBeat
MSN Money - MSN
Sotera Health (SHC) Expected to Announce Earnings on Thursday - MarketBeat
Sotera Health Company (SHC) Stock Analysis: A Promising 19.38% Potential Upside Captures Investor Attention - DirectorsTalk Interviews
Sotera Health Company to Release Fourth-Quarter and Full-Year 2025 Financial Results on February 24, 2026 - Quiver Quantitative
Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date - Yahoo Finance
Sotera Health to post 2025 results, host Feb. 24 investor call - Stock Titan
Brokerages Set Sotera Health Company (NASDAQ:SHC) PT at $20.00 - Defense World
SHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sotera Health (SHC) director Kyle Richard G files Form 3 showing no shares - Stock Titan
Sotera Health Company (NASDAQ:SHC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Former Timken CEO joins board of Sotera Health - Crain's Cleveland Business
Sotera Health appoints Richard Kyle to board - Medical Buyer
Sotera Health Appoints New Independent Director - Intellectia AI
Former Timken CEO joins Sotera Health board after 2014-24 run - Stock Titan
Is Sotera Health (SHC) Pricing Looked At Again After Recent Pharma Biotech Reassessment? - Yahoo Finance
Sotera Health Co Stock (SHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):